Enliven Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $737k | 29k | 25.50 |
| 2024-06-30 | $249k | 11k | 23.50 |
| 2024-03-31 | $137k | 7.8k | 17.50 |
| 2023-12-31 | $104k | 7.4k | 14.00 |
| 2023-09-30 | $46k | 3.3k | 13.66 |
| 2023-03-31 | $247k | 11k | 21.90 |